The Minneapolis police officer was embroiled in a fraud scandal at a nonprofit that his father led.
Industry
Both sides return to the negotiation table Tuesday in hopes of landing a contract agreement before it expires next week.
A special report on how this former lumber town has rebuilt itself as a high-speed, regional center of enterprise.
The Trump administration and rising interest rates create uncharted territory for bankers and their business customers.
Latest Articles
The Trump administration and rising interest rates create uncharted territory for bankers and their business customers.
Workers are slowly realizing there are options other than driving alone.
Business is bad as street renovation drags into year three.
Leaders are extremely optimistic about national and global economies in 2017 and plan to increase hiring, R&D and capital expenditures.
The scalping business is eating deeper into the business model of teams and venues alike. Some are fighting back, to consumers’ dismay.
A Q&A with Carol Schleif, deputy chief investment officer at Abbot Downing.
The bank allegedly used deceptive practices to get customers to sign up for overdraft protection, resulting in extra fees.
The committee vote is a just a small slice of what’s happening across the Legislature: Onetime ‘no’ votes are slowly shifting to ‘yes,’ and new lawmakers are more inclined to repeal the ban.
If you are not in management, you’ll be entertained nonetheless by this author’s behind-the-scenes tales, and you’ll laugh. If you are hiring, however, “Now for the Disappointing Part” is full of lessons, but it ain’t your father’s HR book.
Company formed after acquisition of Minneapolis-based Amcom Software.
Reports explain why ACA premiums rose and why they may go higher without key ACA provisions.
A new report finds that more than one out of every three cigarettes smoked in Minnesota in 2014 was trafficked in from across state lines.
Her departure aligns with the company’s 20th anniversary.
Detecting cancerous tumors from blood samples is the goal of Illumina and Exact Sciences.
New drug candidate is latest tack in addressing hospital-acquired infections.